Search results
This Ultra-High-Yielding Dividend Stock Solved a Key Pain Point
Motley Fool via Yahoo Finance· 1 hour agoContinuing to pay down that facility would reduce its interest expenses and make it easier to extend...
After fatal crash in Peoria, investigation continues into Dunlap HS student's death
Gannett via AOL· 2 hours agoDepartment report listed the driver of the Ford Fusion as a man from Wyoming, Illinois. He suffered...
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever
Motley Fool via Yahoo Finance· 13 minutes agoWe saw just recently that even otherwise solid income stocks with incredible yields can resort to...
Browns Predicted to ‘Bail’ if Deshaun Watson Fails to Produce
Heavy.com· 10 hours agoDeshaun Watson is heading into a make-or-break season with the Cleveland Browns. Watson is entering...
'Pregnancy discrimination across corporate America is still rampant,' author says
CNBC· 13 minutes agoIn the book, "Women Money Power," financial journalist Josie Cox tells the story of women's fight for financial equality.
'Not an excuse': Mom gets prison for death of diabetic 4-year-old fed mostly soda
The Enquirer via Yahoo News· 1 day agoJust four days before she died, Karmity started showing signs of a "serious medical issue" while at...
Find Purpose as a PA: Your Ultimate Career Guide | Miami Herald Jobs
Miami Herald· 2 hours agoFor people interested in the healthcare field, becoming a physician assistant (PA) could be the perfect way to make a meaningful career change that positively impacts people’s lives? Becoming ...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KTLA-TV Los Angeles· 3 hours agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European ...
Mary Lou Retton Says Her Battle With A 'Rare Form Of Pneumonia' Is A 'Medical Mystery'
Women's Health via Yahoo News· 2 days agoOlympic gymnast Mary Lou Retton is on the path to recovery after battling a "rare form of...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 1 day agoWith its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts. A recent report from ...